ClinicalTrials.gg
RecruitingNCT07833280Updated Sep 22, 2026

Kinesiophobia, Physical Activity, Sleep, and Quality of Life in Women With Chronic Pelvic Pain

An observational study in Chronic Pelvic Pain Syndrome (CPPS), sponsored by Ahi Evran University Education and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by Ahi Evran University Education and Research Hospital · Observational

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
120
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

The study will include women who present to the Obstetrics and Gynecology outpatient clinic of Kırşehir Ahi Evran Training and Research Hospital with complaints of pelvic pain and are diagnosed with PCAS after a detailed examination, as well as healthy women. All included women will be administered the Tampa Kinesiophobia Scale (TKS), the International Physical Activity Questionnaire (Short), the Pittsburgh Sleep Quality Questionnaire (PSQI), and the Short Form 36 (p-36). The control group will consist of women who meet the inclusion and exclusion criteria but are not diagnosed with PCAS.

Read the detailed description

This study is designed as an observational, controlled, cross-sectional study to investigate the relationship between kinesiophobia, physical activity, sleep quality, and health-related quality of life in women with PCAS compared with healthy women.

Women presenting to the Obstetrics and Gynecology outpatient clinic of Kırşehir Ahi Evran Training and Research Hospital with complaints of pelvic pain will undergo a detailed clinical evaluation by an obstetrician-gynecologist. Participants diagnosed with PCAS following clinical assessment and meeting the eligibility criteria will be included in the PCAS group. The control group will consist of healthy women without a diagnosis of PCAS who meet the study's eligibility criteria.

All participants will be informed about the study objectives and procedures, and written informed consent will be obtained before enrollment. Demographic and relevant clinical characteristics will be recorded using a standardized data collection form.

Participants in both groups will undergo a comprehensive assessment using the following validated questionnaires:

Tampa Scale of Kinesiophobia (TSK): To assess fear of movement and fear of injury or reinjury associated with physical activity.

International Physical Activity Questionnaire-Short Form (IPAQ-SF): To evaluate participants' physical activity levels.

Pittsburgh Sleep Quality Index (PSQI): To assess subjective sleep quality and sleep disturbances.

36-Item Short Form Health Survey (SF-36): To evaluate health-related quality of life across physical and mental health domains.

All questionnaires will be administered during a single assessment session. No therapeutic intervention will be provided as part of the study, and participants will continue to receive routine clinical care as appropriate.

The primary objective is to compare kinesiophobia levels between women with PCAS and healthy controls. Secondary objectives are to compare physical activity levels, sleep quality, and health-related quality of life between the groups and to examine the relationships between kinesiophobia and these variables.

The findings are expected to contribute to a better understanding of the physical and psychosocial factors associated with PCAS and may provide a basis for future rehabilitation strategies addressing movement-related fear, physical inactivity, and reduced quality of life.

02

Conditions studied

  • Chronic Pelvic Pain Syndrome (CPPS)

Keywords

  • Chronic pain
  • pelvic pain
  • pelvic pain syndrome
  • Chronic Pelvic Pain Syndrome
  • kinesiophobia
  • sleep quality
  • quality of life
03

In context

Chronic Pain

3,227 studies on the registry are indexed under Chronic Pain; 729 are open to participants now.

This study's planned enrollment of 120 is close to the median of 120 across 753 observational studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Ahi Evran University Education and Research Hospital is the lead sponsor of 39 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

women with chronic pelvic pain

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Being between 18-65 years of age
  2. Having a diagnosis of Chronic Pelvic Pain
  3. Having a pain score of 5 or higher on the visual analog scale
  4. Voluntary participation in the study

Exclusion criteria

Exclusion Criteria:

  1. Not wanting to continue in the study
  2. Presence of neurological or orthopedic disease
  3. Active urinary tract infection or recurrent urinary tract infection (more than 5 recurrent infections in the last 12 months)
  4. Pregnancy
  5. History of surgery in the pelvic region
  6. Learning disability or other cognitive impairments.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
120 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • chronic pelvic pain syndrome

    This cohort will consist of women diagnosed with chronic pelvic pain syndrome (CPPS) following a detailed clinical evaluation by an obstetrician-gynecologist at Kırşehir Ahi Evran Training and Research Hospital. Eligible participants will undergo a single assessment using the Tampa Scale of Kinesiophobia (TSK), International Physical Activity Questionnaire-Short Form (IPAQ-SF), Pittsburgh Sleep Quality Index (PSQI), and 36-Item Short Form Health Survey (SF-36) to evaluate kinesiophobia, physical activity, sleep quality, and health-related quality of life, respectively. No study-specific therapeutic intervention will be administered.

    Other: questionnaire

  • Healthy

    This cohort will consist of healthy women without a diagnosis of chronic pelvic pain syndrome (CPPS) who meet the study's eligibility criteria. Participants will undergo a single assessment using the Tampa Scale of Kinesiophobia (TSK), International Physical Activity Questionnaire-Short Form (IPAQ-SF), Pittsburgh Sleep Quality Index (PSQI), and 36-Item Short Form Health Survey (SF-36) to evaluate kinesiophobia, physical activity, sleep quality, and health-related quality of life, respectively. No study-specific therapeutic intervention will be administered.

    Other: questionnaire

Interventions

  • Otherquestionnaire

    evaluation

06

What researchers measure

Primary outcomes

  1. kinesiophobia

    Kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia (TSK). The scale consists of 17 items rated on a 4-point Likert scale. The total score ranges from 17 to 68, with higher scores indicating greater levels of kinesiophobia.

    Time frame: At baseline (single assessment)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — privacy of personal information

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07833280
Lead sponsor
Ahi Evran University Education and Research Hospital
Responsible party
Esra BAYRAMOĞLU DEMİRDÖĞEN (Lecturer Doctor, Ahi Evran University Education and Research Hospital) — Principal investigator
First posted
Sep 22, 2026
Start date
Feb 1, 2026
Primary completion
Oct 10, 2026 (estimated)
Completion
Oct 15, 2026 (estimated)
Last update
Sep 22, 2026

Study contacts

Esra B. DEMİRDÖĞEN
Contact
esra.bayramoglu@ahievran.edu.tr
05426961169
Esra BAYRAMOĞLU DEMİRDÖĞEN
principal investigator · Kırşehir Eğitim ve Araştırma Hastanesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion